Literature DB >> 13783966

Co58B12 absorption, plasma transport and excretion in patients with myeloproliferative disorders, solid tumors and non-neoplastic diseases.

I B WEINSTEIN, D M WATKIN.   

Abstract

Entities:  

Keywords:  BONE MARROW/diseases; LEUKEMIA, MYELOCYTIC/metabolism; NEOPLASMS/metabolism; VITAMIN B 12/metabolism

Mesh：

Substances：

Year:  1960        PMID： 13783966      PMCID： PMC293407          DOI： 10.1172/JCI104190

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  24 in total

1.  The absorption and utilization of vitamin B12.

Authors:  R F SCHILLING
Journal:  Am J Clin Nutr       Date:  1955 Jan-Feb       Impact factor: 7.045

2.  Radioactive vitamin B12 absorption studies: results of direct measurement of radioactivity in the blood.

Authors:  A DOSCHERHOLMEN; P S HAGEN
Journal:  Blood       Date:  1957-04       Impact factor: 22.113

3.  Further observations on the intestinal absorption of vitamin B12 as measured by hepatic uptake of Co60B12.

Authors:  G B J GLASS; H SCHAFFER
Journal:  Bulletin NY Med Coll       Date:  1956

4.  Plasma, tissue and urinary radioactivity after oral administration of 56Co-labelled vitamin B12.

Authors:  C C BOOTH; D L MOLLIN
Journal:  Br J Haematol       Date:  1956-07       Impact factor: 6.998

5.  [Vitamin B12 metabolism in hemoblastoses. III. Resorption, blood distribution, serum protein binding, retention and excretion of vitamin B12 after oral and parenteral administration in hemoblastoses].

Authors:  S ERDMANN-OEHLECKER; H C HEINRICH
Journal:  Clin Chim Acta       Date:  1956 Jul-Aug       Impact factor: 3.786

6.  The plasma disappearance, excretion, and tissue distribution of cobalt 60 labelled vitamin B12 in normal subjects and patients with chronic myelogenous leukemia.

Authors:  H F CORBUS; A MILLER; J F SULLIVAN
Journal:  J Clin Invest       Date:  1957-01       Impact factor: 14.808

7.  Serum concentrations of vitamin B12 in patients suffering from leukemia.

Authors:  M F BEARD; W R PITNEY; E H SANNEMAN
Journal:  Blood       Date:  1954-08       Impact factor: 22.113

8.  Serum vitamin B12 concentrations in leukaemia and in some other haematological conditions.

Authors:  D L MOLLIN; G I ROSS
Journal:  Br J Haematol       Date:  1955-04       Impact factor: 6.998

9.  Observations on the bound form of vitamin B12 in human serum.

Authors:  W R PITNEY; M F BEARD; E J VAN LOON
Journal:  J Biol Chem       Date:  1954-03       Impact factor: 5.157

10.  The vitamin B12 concentrations of serum and urine of normals and of patients with megaloblastic anaemias and other diseases.

Authors:  D L MOLLIN; G I M ROSS
Journal:  J Clin Pathol       Date:  1952-05       Impact factor: 3.411
View more
  1 in total

1.  [Vitamin B12 binding glycoproteins. VIIth. Unsaturated 57Co-cyanocobalamin binding capacity of glycoproteins in chronic myelogenous leukaemia (author's transl)].

Authors:  G Haffner; E Kallee
Journal:  Klin Wochenschr       Date:  1973-07-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.